直肠癌的线性能量传递优化质子治疗
本研究评估LET优化质子治疗算法在局部晚期直肠癌中的可行性与效用,并对5例标准25次临床质子计划进行LET优化重规划。结果显示LET优化计划提高GTV的LETd和LET加权剂量及CTV5625cGy V100%覆盖,同时降低膀胱和小肠平均LET加权剂量及小肠V30Gy(cc)。临床前模型显示可比LET优化可增加肿瘤疗效并减少小肠放射性肠病。
要点
- LET优化质子计划提高GTV的LETd和LET加权剂量及CTV5625cGy V100%覆盖。
- LET优化降低膀胱和小肠平均LET加权剂量及小肠V30Gy(cc)。
- 临床前模型显示可比LET优化增加肿瘤疗效并减少小肠放射性肠病。
核心结论
- LET优化质子计划在保持或改善靶区覆盖和OAR保护的同时增加大体肿瘤的LETd,计划稳健性可接受。
- 临床前模型表明可比LET优化可能增加直肠癌肿瘤疗效并减少正常组织毒性。
研究设计与样本
- 对5例接受标准25次临床质子治疗的直肠癌患者,使用LET优化治疗规划算法重新规划并评估剂量学终点。
- LET优化算法迭代增加GTV中高LET点和OARs中低LET点的权重。
- 使用与临床LET优化计划中达到的LETd范围相当的小鼠和体外临床前模型评估肿瘤疗效和正常组织毒性。
主要发现
- LET优化质子计划增加GTV的剂量平均LET(LETd)和GTV的LET加权剂量,以及CTV5625cGy V100%覆盖。
- 与标准质子计划相比,LET优化降低膀胱和小肠的平均LET加权剂量以及小肠V30Gy(cc)。
- 将LETd优化至GTV-3 mm体积相比整个GTV进一步增加LETd。
- 临床前模型中,LET优化在体外增加结直肠癌细胞系的肿瘤疗效,在小鼠正常组织毒性模型中减少小肠放射性肠病。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the feasibility and utility of an LET-optimized proton treatment planning algorithm in locally advanced rectal cancer and to assess whether the degree of LET-optimization achieved in clinical plans improves efficacy and toxicity in preclinical models. MATERIALS AND METHODS: A series of five rectal cancer patients treated with standard 25 fraction clinical proton plans were re-planned using an LET-optimization treatment planning algorithm and evaluated for dosimetric endpoints. LET-optimized plans were generated using an algorithm which iteratively increases the weights of higher LET spots in GTV and lower LET in OARs. Murine and in vitro preclinical models of tumor efficacy and normal tissue toxicity were evaluated using comparable LETd range to that achieved in clinical LET-optimized plans. RESULTS: LET-optimized proton plans increased dose-averaged LET (LETd) in the GTV and LET-weighted dose in the GTV, and CTV5625cGy V100% coverage. At the same time, LET-optimization also decreased mean LET-weighted dose to bladder and small bowel, as well as small bowel V30Gy(cc) compared to standard proton plans. Optimizing the LETd to a volume of GTV-3 mm further increased LETd compared to total GTV. LET-optimization in preclinical models increased tumor efficacy in colorectal cancer cell lines in vitro and decreased small bowel radiation enteropathy in murine models of normal tissue toxicity. CONCLUSIONS: LET-optimized proton plans increased LETd in gross tumor while maintaining or improving target coverage and OAR sparing, with acceptable plan robustness. Preclinical models demonstrated that comparable LET-optimization may increase tumor efficacy and decrease normal tissue toxicity in rectal cancer.
引用
- Ma J, Dragojevic S, Remmes NB, et al. Linear energy transfer optimized proton therapy for rectal cancer. Radiother Oncol. 2025. PMID: 40101854. doi:10.1016/j.radonc.2025.110850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。